KR900006116B1 - 신규 디히드로피리딘의 제조 방법 - Google Patents

신규 디히드로피리딘의 제조 방법 Download PDF

Info

Publication number
KR900006116B1
KR900006116B1 KR1019830002236A KR830002236A KR900006116B1 KR 900006116 B1 KR900006116 B1 KR 900006116B1 KR 1019830002236 A KR1019830002236 A KR 1019830002236A KR 830002236 A KR830002236 A KR 830002236A KR 900006116 B1 KR900006116 B1 KR 900006116B1
Authority
KR
South Korea
Prior art keywords
ethyl
dimethyl
dihydropyridine
dicarboxylic acid
dichlorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019830002236A
Other languages
English (en)
Korean (ko)
Other versions
KR840004724A (ko
Inventor
베른 하르트 베른트슨 페더
에케 잉게마르 칼슨 스티히
Original Assignee
악티 볼라게트 헤슬레
키엘 호름 키스트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 악티 볼라게트 헤슬레, 키엘 호름 키스트 filed Critical 악티 볼라게트 헤슬레
Publication of KR840004724A publication Critical patent/KR840004724A/ko
Application granted granted Critical
Publication of KR900006116B1 publication Critical patent/KR900006116B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
KR1019830002236A 1982-05-21 1983-05-21 신규 디히드로피리딘의 제조 방법 Expired KR900006116B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8203177 1982-05-21
SE8203177-4 1982-05-21

Publications (2)

Publication Number Publication Date
KR840004724A KR840004724A (ko) 1984-10-24
KR900006116B1 true KR900006116B1 (ko) 1990-08-22

Family

ID=20346868

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830002236A Expired KR900006116B1 (ko) 1982-05-21 1983-05-21 신규 디히드로피리딘의 제조 방법

Country Status (19)

Country Link
EP (1) EP0095450A3 (enExample)
JP (1) JPS58210064A (enExample)
KR (1) KR900006116B1 (enExample)
AU (1) AU1464483A (enExample)
CA (1) CA1242201A (enExample)
DD (2) DD216454A5 (enExample)
DK (1) DK223783A (enExample)
ES (4) ES522573A0 (enExample)
FI (1) FI79300C (enExample)
GB (1) GB2120251B (enExample)
GR (1) GR78849B (enExample)
HU (2) HU193785B (enExample)
IL (1) IL68604A0 (enExample)
IS (1) IS1380B6 (enExample)
MW (1) MW2083A1 (enExample)
NO (1) NO162515C (enExample)
NZ (1) NZ204284A (enExample)
PT (1) PT76734B (enExample)
ZA (1) ZA833264B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930011486B1 (ko) * 1985-08-06 1993-12-08 베링거 만하임 이탈리아 에스.피.에이. 제약상 유효한 2-티오메틸-치환-1,4-디히드로피리딘
IT1204421B (it) * 1986-06-27 1989-03-01 Boehringer Biochemia Srl 2-(aminoalchiltio)metil-1,4-diidropiridine,un metodo per la loro preparazione e composizioni farmaceutiche che le contengono
IT1197012B (it) * 1986-07-29 1988-11-25 Boehringer Biochemia Srl 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.
IT1213440B (it) * 1986-12-24 1989-12-20 Boehringer Biochemia Srl 2-ditioalchil-diidropiridine, un metodo per la loro preparazione e composizioni farmaceutiche chele contengono.
IT1204948B (it) * 1987-03-13 1989-03-10 Boheringer Biochemia Robin S P 2-tiometil-sostituite-piridine, metodo per la loro preparazione e composizioni farmaceutiche che le contengono.
DE3741540A1 (de) * 1987-12-08 1989-06-22 Bayer Ag Verfahren zur herstellung von unsymmetrischen dihydropyridinen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
DE2740080A1 (de) * 1977-09-06 1979-03-15 Bayer Ag 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
GB2050375B (en) * 1979-05-11 1983-02-23 Fujisawa Pharmaceutical Co 4-cyanophenyl-1,4-dihydropyridine compound processes for preparation thereof and pharmaceutical composition comprising the same
SE7910521L (sv) * 1979-12-20 1981-06-21 Haessle Ab Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma

Also Published As

Publication number Publication date
PT76734B (en) 1986-03-27
FI831779L (fi) 1983-11-22
GB2120251B (en) 1985-11-27
DD216454A5 (de) 1984-12-12
ES542186A0 (es) 1985-12-16
FI79300B (fi) 1989-08-31
EP0095450A3 (en) 1984-09-05
ES542187A0 (es) 1985-12-16
ZA833264B (en) 1984-06-27
ES8600242A1 (es) 1985-10-01
KR840004724A (ko) 1984-10-24
NO831807L (no) 1983-11-22
ES542185A0 (es) 1985-12-16
ES522573A0 (es) 1985-10-01
AU1464483A (en) 1983-11-24
GR78849B (enExample) 1984-10-02
IS2808A7 (is) 1983-11-22
IS1380B6 (is) 1989-08-28
ES8603416A1 (es) 1985-12-16
CA1242201A (en) 1988-09-20
GB2120251A (en) 1983-11-30
FI831779A0 (fi) 1983-05-19
DK223783D0 (da) 1983-05-19
PT76734A (en) 1983-06-01
JPS58210064A (ja) 1983-12-07
ES8603415A1 (es) 1985-12-16
DD211554A5 (de) 1984-07-18
IL68604A0 (en) 1983-09-30
GB8314021D0 (en) 1983-06-29
EP0095450A2 (en) 1983-11-30
NO162515C (no) 1990-01-10
FI79300C (fi) 1989-12-11
HU193785B (en) 1987-11-30
DK223783A (da) 1983-11-22
NZ204284A (en) 1985-11-08
ES8603417A1 (es) 1985-12-16
HU188343B (en) 1986-04-28
MW2083A1 (en) 1985-06-12
NO162515B (no) 1989-10-02

Similar Documents

Publication Publication Date Title
JPS6121550B2 (enExample)
CS228917B2 (en) Method of preparing substituted derivatives of 1,4-dihydropyridine
KR900006116B1 (ko) 신규 디히드로피리딘의 제조 방법
RU2330843C2 (ru) Амлодипина гентизат и способ его получения
CN114349745B (zh) 一种用于治疗心肌缺血的药物及其制备方法
JPS58210063A (ja) 新規なジヒドロピリジン類
US4177291A (en) Compounds having antidepressive activity
JP2577994B2 (ja) 脳血流増加剤
KR0148755B1 (ko) 신규 테트라하이드로이소퀴놀린계 화합물 및 그의 염
JPS5852286A (ja) 新規なジヒドロピリジン化合物
DK162442B (da) 3-(2-(furoyl)-5-(eventuelt substitueret)alkoxy-carbonyl-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridiner og farmaceutisk praeparat indeholdende saadanne forbindelser
EP0249174A1 (en) 1,4-dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions containing same
JPS6013028B2 (ja) 抗抑うつ活性を有するトリフルオロメチル置換化合物
CH628321A5 (en) Process for the preparation of derivatives of isobutyramide and medical composition containing these derivatives
JPS58121214A (ja) 血小板凝集阻害剤
SI21066A2 (sl) Amlodipin fumarat
NO167455B (no) Mellomprodukter
KR20050041281A (ko) 암로디핀 히퓨레이트 염과 이의 제조방법
FR2626177A1 (fr) Nouveaux derives de l'ergoline, leur preparation et leur utilisation comme medicaments
MC1675A1 (fr) Dérivés de dihydropyridine
FR2543954A1 (fr) Acylamino-4 aza-1 adamantanes, procede pour leur preparation et application en therapeutique
KR20050041282A (ko) 암로디핀 니코티네이트 염과 이의 제조방법
JPH02275880A (ja) １，４―ジヒドロ―５―イソプロポキシ―２―メチル―４―（２―トリフルオロメチル―フェニル）―１，６―ナフチリジン―３―カルボン酸［２―（ｎ―メチル―ｎ―フェニルメチルアミノ）―エチル］エステルフマル酸塩
CS241038B2 (cs) Způsob výroby 3-methyl-5-ethylesteru kyseliny 2,6-dimethyl-4-(2,3-dichlorfenyl)-l,4-dihydropyridin-3,S- -dikarboxylové
JPH08208477A (ja) 血管内皮保護剤

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 19960809

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19970823

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19970823